Journals / Turkish journal of physical medicine and rehabilitation / 2019 / Cilt: 65 - Sayı: 4

The relationship of serum vitamin D receptor levels with disease activity and clinical parameters in patients with ankylosing spondylitis

Pages
389–393
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The SVDR levelswere positively correlated with the BASDAI, CRP and ESR in the patient group (p=0.01, r=0.751; p=0.01, r=0.75; p=0.01, r=0.81, respectively).Conclusion: Our study results suggest that serum SVDR levels are associated with the disease activity and clinical parameters in patientswith AS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to investigate the relationship between serum vitamin D receptor (SVDR) levels and disease activity parameters in patients with ankylosing spondylitis (AS).Patients and methods: Between July 2016 and January 2017, a total of 62 patients (51 males, 11 females; mean age 36.5±12.8 years;range, 23 to 49 years) with AS and 32 healthy volunteers (25 males, 7 females; mean age 41.57±13.6 years; range, 26 to 48 years) were includedin the study.
📊
Key Findings & Data:Erythrocyte sedimentation rate (ESR) andserum C-reactive protein (CRP) levels were recorded.
💡
Conclusion & Impact:The SVDR levelswere positively correlated with the BASDAI, CRP and ESR in the patient group (p=0.01, r=0.751; p=0.01, r=0.75; p=0.01, r=0.81, respectively).Conclusion: Our study results suggest that serum SVDR levels are associated with the disease activity and clinical parameters in patientswith AS.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: The aim of this study was to investigate the relationship between serum vitamin D receptor (SVDR) levels and disease activity parameters in patients with ankylosing spondylitis (AS).Patients and methods: Between July 2016 and January 2017, a total of 62 patients (51 males, 11 females; mean age 36.5±12.8 years;range, 23 to 49 years) with AS and 32 healthy volunteers (25 males, 7 females; mean age 41.57±13.6 years; range, 26 to 48 years) were includedin the study. The SVDR levels were measured using the enzyme-linked immunosorbent assay. Erythrocyte sedimentation rate (ESR) andserum C-reactive protein (CRP) levels were recorded. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores were usedto assess disease activity.Results: Although there was no significant difference between the patient and control groups (p=0.66), SVDR levels were significantlyelevated in patients with active AS (BASDAI score ≥4) (p=0.01). The SVDR levels significantly increased in AS patients with peripheral jointinvolvement and enthesitis (p=0.01, p=0.05, respectively). The SVDR levels significantly elevated in patients treated with non-steroidal antiinflammatorydrugs, compared to those treated with biological agents and control group (p=0.01, p=0.03, respectively). The SVDR levelswere positively correlated with the BASDAI, CRP and ESR in the patient group (p=0.01, r=0.751; p=0.01, r=0.75; p=0.01, r=0.81, respectively).Conclusion: Our study results suggest that serum SVDR levels are associated with the disease activity and clinical parameters in patientswith AS. Based on these findings, SVDR level may be used as a marker of disease activity in AS.

🔖

Cite This Article

KÜLTÜR, T., ÖZTAŞ, D., KESKİN, E. D., KESKİN, G., İNAL, A., KARA, H. (2019). The relationship of serum vitamin D receptor levels with disease activity and clinical parameters in patients with ankylosing spondylitis. Turkish journal of physical medicine and rehabilitation, Cilt: 65 - Sayı: 4, 389–393. https://ajindex.com/articles/375287

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Feldtkeller E, Erlendsson J. Definition of disease duration in ankylosing spondylitis. Rheumatol Int 2008;28:693-6
  2. Reveille JD. Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis. Clin Rheumatol 2015;34:1009-18
  3. Zhao S, Duffield SJ, Moots RJ, Goodson NJ. Systematic review of association between vitamin D levels and susceptibility and disease activity of ankylosing spondylitis. Rheumatology (Oxford) 2014;53:1595-603
  4. Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med 2011;11:325-35
  5. Adorini L, Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008;4:404-12
  6. Zhang P, Li Q, Qi J, Lv Q, Zheng X, Wu X, et al. Association between vitamin D receptor gene polymorphism and ankylosing spondylitis in Han Chinese. Int J Rheum Dis 2017;20:1510-6
  7. Rosca C, Cheung N. Does correction of vitamin d level influence the disease activity and functionality in ankylosing spondylitis patients? A longitudinal study. Rheumatology 2017;56(Suppl 2):209
  8. Muralidhar S, Nsengimana J, Pozniak J, O’Shea S, Laye J, Adams D, et al. Primary melanoma expression of the vitamin D receptor (VDR) is protective for melanoma survival and is associated with increased tumor immune response, decreased Wnt/B-catenin signaling and tumor proliferation. Proceedings of the American Association for Cancer Research Annual Meeting, April 14-18, 2018, Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2018;78(13 Suppl):5205
  9. Singh RK, Turner R, Kim K, Sivagnanalingam U, Moore RG. Targeting vitamin D receptor (VDR)/immune checkpoint inhibitor receptor ligand PD-L1 axis for immunotherapy of ovarian cancer. Gynecologic Oncology 2018;149:48
  10. Ziv E, Koren R, Zahalka MA, Ravid A. TNF-α increases the expression and activity of vitamin D receptor in keratinocytes: role of c-Jun N-terminal kinase. Dermatoendocrinol 2016;8:e1137399
  11. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005;25:280-4
  12. Yin K, Agrawal DK. Vitamin D and inflammatory diseases. J Inflamm Res 2014;7:69-87
  13. Chang SH, Chung Y, Dong C. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J Biol Chem 2010;285:38751-5
  14. Stubbs JR, Idiculla A, Slusser J, Menard R, Q